PFE
Pfizer, Inc.
Mature Trend, sector confirmed; strongest on regime (16/20); weakest on sector alignment (9/20). Last earnings shrugged off (+1.5%); 3 insiders buying.
Mature Trend
XLV
sector confirmed
no CFO purchase$2,960,110 other insiders (3)
3 insider(s)
net purchase ratio +0.91
buy date unknown
64
conviction / 100
unchanged since 26 Aug
65.9
technical / 100
$17,500–$24,500
Standard · sized down 30% for campaign stage (Mature Trend)
Regime clarity16.1
Sponsorship / positioning11.6
Volatility behaviour15.8
Catalyst alignment (insider)11.5
Cross-asset confirmation9.2
Last
28.30
Add above
28.58
Cut below
23.26
50DMA
25.27
200DMA
25.29
PFE — daily, 14 months
XLV — sector ETF, daily, 14 months
Pillar detail, thesis support and invalidation
Regime clarity
What strengthens the thesis
- price above 200DMA
- 200DMA rising
- 50DMA rising
- partial HH/HL structure
- efficiency ratio 0.18
- OBV 50d slope +0.138 avg-daily-volumes/bar
- no OBV divergence at highs
- OBV fell through last pullback
- last pullback 12.6% deep
- no wide downside expansion bars (30d)
- ATR expanding vs 20d mean
- cluster: 3 distinct insiders buying (1 CEO, 2 Director)
- net purchase ratio +0.91 (3 buying vs 1 selling)
- NO CFO purchase in the window — the CFO-specific terms score zero
- other insiders bought $2,960,110 (1 CEO, 2 Director) — counted through cluster breadth and net buying only
- no CFO buy to date — recency not scored
- closest sector ETF: XLV
- XLV above rising 200DMA (sector-led)
- XLV vs SPY 6m: -0.2 pts
- stock vs XLV RS (3m/6m avg): -5.1 pts
- A confirmed higher high above 28.58 on expanding OBV.
- Pullbacks that hold the rising 50DMA with flat-to-rising OBV.
- XLV extending its own trend while the stock holds relative strength.
- Loss of the rising 50DMA (25.27) with expanding volatility — reduce.
- Breakdown below the prior structural base (23.26) — exit, no averaging down.
- OBV divergence during a price acceleration — reduce.
- Sector ETF losing its own 200DMA — remove capital regardless of stock behaviour.
- CFO: —
- 0 CFO purchase(s), $0 total; last filed 2026-08-12 16:04:39
- Market cap $161,300,758,528 · 20d avg dollar volume $1,058,465,072
Net buying across the insider group.
| Open-market purchases | $2,960,110 |
| Open-market sales | $134,661 |
| Sales after option exercise | $0 |
| Distinct buyers / sellers | 3 / 1 |
| Net purchase ratio | +0.91 |
| Net purchase ratio, excl. option-exercise sales | +0.91 |
No CFO purchase here — 3 purchase(s) by other insiders worth $2,960,110. These count toward cluster breadth and net buying, not the CFO-specific terms.
| Trade date | Insider | Shares | Price | Value | Price now vs buy |
|---|---|---|---|---|---|
| 05 Aug 2026 | Blaylock Ronald EDirector | 39,231 | $25.46 | $998,821 | +11.2% |
| 05 Aug 2026 | Buckley Mortimer JDirector | 37,632 | $25.52 | $960,369 | +10.9% |
| 12 Aug 2026 | Bourla AlbertCEO | 38,000 | $26.34 | $1,000,920 | +7.4% |
7 material events; 4 taken well, 0 badly; last earnings 04 Aug: shrugged off (+1.5%).
| Session | Filing | Event | Gap | Day | vs SPY | Vol | +5d | Read |
|---|---|---|---|---|---|---|---|---|
| 04 Aug 26 | 8-K · earnings | Results of operations (earnings) | +0.0% | +1.5% | -0.3% | 1.6x | +4.8% | Shrugged off |
| 04 Aug 26 | 10-Q | Quarterly report | +0.0% | +1.5% | -0.3% | 1.6x | +4.8% | Shrugged off |
| 18 Jun 26 | 8-K | Director or officer change | -1.3% | -2.7% | -3.8% | 3.5x | -3.6% | Neutral |
| 18 Jun 26 | 8-K | Regulation FD disclosure | -1.3% | -2.7% | -3.8% | 3.5x | -3.6% | Neutral |
| 05 May 26 | 8-K · earnings | Results of operations (earnings) | +1.1% | +0.6% | -0.2% | 1.7x | -0.6% | Shrugged off |
| 05 May 26 | 10-Q | Quarterly report | +1.1% | +0.6% | -0.2% | 1.7x | -0.6% | Shrugged off |
| 27 Apr 26 | 8-K | Material event | +0.2% | -0.8% | -1.0% | 1.0x | -1.8% | Neutral |